Evidence suggests that inhibition of IRE1 (Rnase site) leads to decreased splicing of XBP1, which reduces cell proliferation and increases apoptosis in breast cancer (Ming et al., 2015), pancreatic cancer (Chien et al., 2014), and multiple myeloma (Chen et al., 2016). Here, ERN1 is linked to plasma cell myeloma.